Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) EPS (Basic): ¥0.97 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688076 Sinopep Allsino Bio Pharmaceutical Co Ltd SHSE:688076
65 GF Score
Price ¥28.00
GF Value ¥58.87
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Sinopep Allsino Bio Pharmaceutical Co EPS (Basic)?

Sinopep Allsino Bio Pharmaceutical Co SHSE:688076 -4.18% 65 EPS (Basic) is ¥0.97 as of Mar. 2026. GuruFocus rates SHSE:688076 with a GF Score™ of 65/100 and a GF Value™ of ¥58.87 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Sinopep Allsino Bio Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ¥0.41. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.97.

Sinopep Allsino Bio Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2026 was ¥0.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.97.

Sinopep Allsino Bio Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2026 was ¥0.50. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 1.28.

During the past 12 months, Sinopep Allsino Bio Pharmaceutical Co's average EPS without NRIGrowth Rate was -26.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 44.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sinopep Allsino Bio Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 44.20% per year. The lowest was -2.30% per year. And the median was 30.40% per year.

Sinopep Allsino Bio Pharmaceutical Co  (SHSE:688076) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sinopep Allsino Bio Pharmaceutical Co EPS (Basic) Related Terms

Sinopep Allsino Bio Pharmaceutical Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Sinopep Allsino Bio Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopep Allsino Bio Pharmaceutical Co EPS (Basic) Chart

Sinopep Allsino Bio Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.43 0.54 1.34 1.06

Sinopep Allsino Bio Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.49 0.43 -0.36 0.41
SHSE:688076
65GF Score
Sinopep Allsino Bio Pharmaceutical Co Ltd SHSE:688076
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinopep Allsino Bio Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sinopep Allsino Bio Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(332.419-0)/313.603
=1.06

Sinopep Allsino Bio Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(129.463-0)/315.764
=0.41

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ¥0.97 mean?
Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) has a EPS (Basic) of ¥0.97 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sinopep Allsino Bio Pharmaceutical Co and its competitors.
Is Sinopep Allsino Bio Pharmaceutical Co's EPS (Basic) too high?
Sinopep Allsino Bio Pharmaceutical Co's current EPS (Basic) is ¥0.97. Overall, Sinopep Allsino Bio Pharmaceutical Co has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopep Allsino Bio Pharmaceutical Co's EPS (Basic) compare to VRTX and REGN?
Sinopep Allsino Bio Pharmaceutical Co's EPS (Basic) of ¥0.97 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sinopep Allsino Bio Pharmaceutical Co and its competitors. Sinopep Allsino Bio Pharmaceutical Co's current EPS (Basic) is ¥0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopep Allsino Bio Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥58.87, compared to a current price of ¥28.00 — trading 52.4% below its estimated fair value. The current EPS (Basic) is ¥0.97. Sinopep Allsino Bio Pharmaceutical Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076), the current EPS (Basic) is ¥0.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Overvalued in 2026?

Based on GuruFocus' analysis, Sinopep Allsino Bio Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥28.00 is trading 52.4% below its estimated GF Value™ of ¥58.87. GuruFocus considers Sinopep Allsino Bio Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:688076:

  • EPS (Basic): ¥0.97
  • GF Value™: ¥58.87 vs. price of ¥28.00 (52.4% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sinopep Allsino Bio Pharmaceutical Co Business Description

Address No. 28, Linpu Road, Economic and Technological Development Zone, Jiangsu Province, Lianyungang, CHN, 222069
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.
65GF Score

Get the complete analysis for SHSE:688076

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.00
Price
¥58.87
GF Value